PROPHYLACTIC LASER TREATMENT TO DECREASE THE INCIDENCE OF RETINAL DETACHMENT IN FELLOW EYES OF IDIOPATHIC GIANT RETINAL TEARS by Verhoekx, J.S.N. (Jennifer) et al.
D
ow
nloaded
from
https://journals.lw
w
.com
/retinajournalby
B
hD
M
f5eP
H
K
av1zE
oum
1tQ
fN
4a+kJLhE
ZgbsIH
o4X
M
i0hC
yw
C
X
1A
W
nY
Q
p/IlQ
rH
D
3hZG
kqA
3H
Y
LN
G
1i3f3kU
b63D
R
X
Y
+xFz2xX
V
V
IV
Fc0C
aM
=
on
07/16/2020
Downloadedfromhttps://journals.lww.com/retinajournalbyBhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3hZGkqA3HYLNG1i3f3kUb63DRXY+xFz2xXVVIVFc0CaM=on07/16/2020
PROPHYLACTIC LASER TREATMENT TO
DECREASE THE INCIDENCE OF RETINAL
DETACHMENT IN FELLOW EYES OF
IDIOPATHIC GIANT RETINAL TEARS
JENNIFER S. N. VERHOEKX, MD, PHD,* PETER G. VAN ETTEN, MD,* RENE J. WUBBELS, PHD,†
JAN C. VAN MEURS, MD, PHD,*‡ KOEN A. VAN OVERDAM, MD*†
Purpose: To evaluate the effectiveness of prophylactic 360° laser treatment in the fellow
eye of patients with unilateral idiopathic giant retinal tear (GRT) to prevent the occurrence of
a (macula-off) retinal detachment.
Methods: We conducted a retrospective, nonrandomized case–control study. Clinical
data of consecutive patients, undergoing surgery for idiopathic GRT, between 2003 and
2015 were analyzed. The data collected included GRT, retinal detachment, and RTs in the
fellow eye.
Results: We included 129 patients who underwent surgery for an idiopathic GRT, with
a mean follow-up period of 107 months. In the observation group, a retinal detachment
developed in the fellow eye in 22/51 patients (43.1%), leading to a macula-off detachment
in 9/51 patients (17.6%). By contrast, in the prophylactic 360° laser group, only 10/78
(12.8%) patients developed a retinal detachment, leading to a macula-off detachment in
1/78 patient (1.3%). This difference was statistically significant.
Conclusion: This study suggests that prophylactic 360° laser treatment in the fellow eye
of patients with an idiopathic GRT decreased the incidence of retinal detachment, lowering
the high risk of visual loss due to a macula-off retinal detachment.
RETINA 40:1094–1097, 2020
Giant retinal tear (GRT) is a full-thickness retinal breakextending over 90° or more of the retinal circumfer-
ence, posterior to the ora serrata in the presence of a poste-
riorly detached vitreous. The estimated incidence of GRT is
0.094 to 0.114 cases per 100,000 annually in the general
U.K. population.1 Giant retinal tears were mostly idiopathic
(55%), affected middle-aged male patients (72%), and had
a presenting vision worse than 20/40 in 60% of the cases
with 54% achieving final vision worse than 20/40.1–3
The fellow eye of patients with an idiopathic GRT
has an increased risk for the development of a GRT
and a retinal detachment (RD). Freeman and Soon
Ang reported the natural history of fellow eyes and
reported a 13% incidence of GRT and 36% incidence
of a RD.1,4 These incidences represent a high risk of
visual loss due to an RD in fellow eyes.
This provides a strong argument in favor of 360° pro-
phylactic interventions in fellow eyes of patients who have
had a GRT. There is currently no consensus on the need
of prophylactic treatment, type of treatment, and location
of treatment.5 The purpose of this study is to further
investigate the hypothesis that prophylactic 360° laser
treatment (PLT) in the fellow eye of patients with unilat-
eral idiopathic GRT reduces the occurrence rate of an RD.
Methods
We performed a retrospective, nonrandomized
case–control study. Clinical data of consecutive
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patients, undergoing surgery for idiopathic GRT
between 2003 and 2015, were analyzed. Giant retinal
tear was defined as a full-thickness retinal break ex-
tending for 90 or more degrees of the retinal circum-
ference posterior to the ora serrata. The PLT consisted
of 3 to 4 rows of 360° argon laser 200 mm to 400 mm
in diameter anterior of the equator, posterior to the
presumed vitreous base, until a light gray intensity
burn was achieved. The data collected included age,
sex, refraction, size of RT, macula-on or macula-off,
visual acuity in Snellen, surgeon, surgical procedure,
recurrence of detachment, time from diagnosis till pro-
phylactic treatment, GRT in fellow eye, RD in fellow
eye, RT in fellow eye, time from diagnosis till retinal
event in fellow eye, epiretinal membrane formation,
uveitis, and cystoid macular edema. In the absence
of a strict institutional protocol, scheduling prophylac-
tic treatment was dependent on the surgeon’s preferred
practice, but also by the choices of consultants, fellows
or residents involved in follow-up.
We excluded patients with a history of trauma,
Stickler syndrome or other diagnosis of hereditary
syndromes, age at surgery less than 18 years, history
of previous retinal surgery (including prophylactic
scleral buckle or laser) of first or fellow eye, bilateral
presentation of GRT, or a follow-up of less than 3
years.
Patients who had been referred back to their
referring ophthalmologist at any time or patients
whose last visit to the Rotterdam Eye Hospital was
before January 1, 2018, were contacted by telephone
in June 2018 to elucidate whether they had undergone
laser treatment or RD surgery in either eye in another
institution.
Statistical analysis was performed using GraphPad
Prism software (GraphPad Software, Inc, La Jolla,
CA). Statistical significance (P , 0.05) was identified
using a chi-square test.
This study was conducted in accordance with the
principles of the Declaration of Helsinki (October,
2013), the guideline for Good Clinical Practice
(CPMP/ICH/135/95).
Results
We included 135 patients who underwent surgery
for GRT between 2003 and 2015. Fifty-seven patients
received no prophylactic treatment (observation
group), and 78 patients received PLT. Thirty-four
patients had visited the Rotterdam Eye Hospital at
regular intervals up to 2018 and 97 patients who had
not were contacted by telephone, of which four
patients were lost to follow-up. Two patients were
excluded because the GRT was associated to Stickler
syndrome. Table 1 shows no significant difference in
high myopia, clock hours GRT, (macula-off) RD, or
other baseline characteristics of patients presenting
with a GRT in the first eye between the groups. Pa-
tients with GRT were predominantly men (77%), on
average 52 years, and 23% had high myopia, a refrac-
tive error of 26 diopter or more. Follow-up was on
average 107 ± 43 (36–186) months. In the observation
group, an RD developed in 22/51 (43.1%) patients in
the fellow eye, leading to a macula-off detachment in
9/51 (17.6%) patients. In 12/51 (23.5%) patients, the
RD was due to a GRT and in 10/51 (19.6%) patients
due to a smaller-sized RT (Table 2). By contrast, in the
PLT group, only 10/78 (12.8%) patients developed an
RD, in three patients stopping at the laser barrage and
in only one patient (1.3%) leading to a macula-off
detachment. This difference was statistically signifi-
cant (P , 0.001). Smaller-sized RTs without RD
developed in the observation group in 4/51 (7.8%)
patients and in the PLT group in 6/78 (7.7%) patients,
in 2 patients posterior to the laser barrage. Time
between diagnosis of a GRT and PLT of the fellow
eye was on average 3.8 ± 4.9 (0–18) months. Alloca-
tion of prophylactic treatment seemed to be poorly
correlated with the surgeon’s preferred practice (see
Table 1, Supplemental Digital Content 1, http://
links.lww.com/IAE/A983).
Time from diagnosis to the development of a retinal
event in the observation group was on average 39 ± 33
(4–113) months; in the PLT group, this was on aver-
age 40 ± 42 (5–147) months, and time from PLT to
a retinal event was 34 ± 43 (0–143) months.
In the PLT group, one patient developed an RT
within 4 days of laser treatment. Two patients
developed an epiretinal membrane, leading to a vitrec-
tomy 15 months and 31 months after the PLT. No
patients developed clinically diagnosed uveitis or
cystoid macular edema.
Discussion
This study suggests that prophylactic 360° laser
treatment decreased the incidence of RDs due to GRTs
and smaller RTs, and therefore lowering the high risk
of visual loss due to a macula-off RD in fellow eyes.
Our data showed, over a mean follow-up period of 107
months, that an RD developed in the fellow eye in the
PLT group in 10/78 (12.8%) patients, leading to a mac-
ula-off detachment in only 1/78 patient. In stark con-
trast, in the observation group, 22/51 (43.1%) patients
developed an RD, leading to a macula-off detachment
in 9/51 patients.
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Ripandelli et al6 reported, over a mean follow-up
period of 40 months, that in the PLT group, 13/98
(13.3%) patients developed an RD, not leading to
a macula-off detachment. In the observation group,
11/62 (17.8%) patients developed an RD, leading to
a macula-off detachment in 9/11 patients. Similarly to
our study, Ripandelli et al6 found in the PLT group
more preequatorial RDs not leading to a macula-off
detachment, suggesting that the PLT prevents a local-
ized RD to progress to a macula-off detachment. In
the observation group, we found an RD in 24/51
patients (47.1%), compared with 11/62 (17.8%) pa-
tients in the study of Ripandelli et al.6 Our higher
percentage of RDs might be explained by our longer
follow-up, 107 months versus 40 months. Further-
more, we observed that an RD developed on average
at 39 months.
The advantage of 360‐degree laser is that it can be
performed as an outpatient procedure, preferably in
two sessions reducing discomfort and potential side
effects. However, prophylactic interventions may not
be without adverse events, such as possibly epiretinal
membrane formation, iatrogenic tears, uveitis and cys-
toid macular edema.7 Although the formation of an
epiretinal membrane after prophylactic interventions
has been discussed extensively, there is no convincing
evidence yet that it is not primarily related to the
treated vitreoretinal disorder.8 Also, epiretinal mem-
branes are relatively common among the aged popu-
lation, with a prevalence of 1.4–16.1%.9 In the
prophylactic 360‐degree laser treatment group three
patients developed an epiretinal membrane (3.8%),
leading to a vitrectomy in two patients, and one patient
developed a RT within 4 days. By contrast, Ripandelli
Table 1. Demographics and Background Characteristics
Variable No Treatment PLT P‐value
Mean age at surgery ± SD (range) 51.9 ± 9.6 (20–74) 52.5 ± 9.9 (26–80) ns
Total patients 51 78 ns
Male 38 61
Female 13 17
Spherical refraction ± SD (range) 22.3 ± 4.2 (212 to +1) 22.1 ± 4.2 (216 to +3) ns
High myopia, 26D or more 13/51 16/78 ns
GRT, clock hours ± SD (range) 4.0 ± 1.0 (3–6) 4.0 ± 1.2 (3–7) ns
RD, quadrants 2.4 ± 0.7 (1–4) 2.3 ± 0.8 (0–4) ns
Macula-off detachment 19/51 38/78 ns
Baseline visual acuity (BCVA ± SD) 20/80; 0.26 ± 0.35 20/80; 0.23 ± 0.28 ns
Follow-up in months ± SD (range) 103 ± 43 (38–181) 110 ± 44 (36–186) ns
SD, standard deviation; NS, not significant; D, dioptre; PLT, prophylactic 360‐degree laser; GRT, giant retinal tear. RD, retinal detach-
ment BCVA, best corrected visual acuity in Snellen.
Table 2. Retinal Events in Fellow Eyes During Follow-up
Variable Observation PLT P‐value
Time (months) to PLT ± SD (range) 3.8 ± 4.9 (0–18)
Time (months) from diagnosis to
retinal event ± SD (range)
38 ± 34 (8–113) 40 ± 43 (0–143) ns
Time (months) from PLT to retinal
event ± SD (range)
34 ± 42 (5–147)
RD due to GRT 12/51 (23.5%) 2/78 (2.6%) ,0.001
Leading to macula-off
detachment
5/51 (9.8%) 0/78 (0.0%) ,0.01
RD due to smaller RT 10/51 (19.6%) 8/78 (10.5%) ,0.001 ns
Leading to macula-off
detachment
4/51 (7.8%) 1/78 (1.3%) ns
RD due to GRT and smaller RT
combined
22/51 (43.1%) 10/78 (12.8%) ,0.001
Leading to macula-off
detachment
9/51 (17.6%) 1/78 (1.3%) ,0.001
Smaller RT, without RD 4/51 (7.8%) 6/78 (7.7%) ns
All retinal events combined 26/51 (51.0%) 16/78 (20.5%) ,0.001
PLT, prophylactic 360‐degree laser; NS, not significant; SD, standard deviation; GRT, giant retinal tear; RD, retinal detachment; RT,
retinal tear.
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et al6 reported no epiretinal membrane formation in 98
patients. Although we do not know whether these
events were related to the PLT, as they were 15
months and 31 months after PLT, we did not observe
these events in the observation group. Follow-up in all
cases of patients having PLT is paramount. Nonethe-
less, in our opinion, the visual consequences of these
complications of PLT compare favorably with the inci-
dence and morbidity of RD in the observation group.
Drawbacks of our study are its retrospective nature,
the lack of randomization, and the inability to follow-up
all patients in our institution. In a retrospective study the
composition of the treated and control group are of major
concern. One of the best situations would be that
different surgeons would have fixed different treatment
protocols while they treat the same case-mix of patients.
If such a situation is not present, unequal distribution
among groups is likely to occur due to bias by diagnosis:
i.e. the vitreoretinal surgeons and other doctors involved
in postoperative care might not schedule prophylactic
treatment when a posterior vitreous detachment is
observed, whereas patients with lesions like lattice,
traction and white without pressure would be scheduled
for PLT. This would typically lead to a treatment group
with patients with more potential risk factors, masking
a potential treatment effect. It turned out to be different in
our Institution: two vitreoretinal surgeons, who treated
over 70 patients, professed to schedule all GRT patients
for PLT, but now learned that through a variety of
logistical reasons treatment had not taken place, suggest-
ing that logistic and organisational factors rather than
bias by diagnosis prevented PLT. This assumption is
more likely as the groups were found to be comparable
in recorded risk factors in treatment.
Although not all follow-up data were recorded in our
own Institution, telephonic consultation confirmed that the
referral pattern for vitreoretinal events had not changed
and that patient follow-up data are likely to be complete.
Strong points of our study are that it concerns
a consecutive and large series of patients, a lengthy
follow-up, and that the risk characteristics of patients
presenting with a GRT in the first eye between the
observation group and prophylactic treatment group
were equal.
It is well established that the fellow eye of patients
with GRT has an increased risk of GRT and RD, and
that a GRT and/or an RD represent a high risk of
visual loss. Our data, and others, show that a GRT and
an RD in the fellow eye occurred statistically and
clinically significantly less frequently after prophylac-
tic 360° laser treatment than in the observation group.6
We therefore would advocate a prophylactic 360° laser
treatment in fellow eyes of patients with an idiopathic
GRT.
Key words: giant retinal tear, laser, prophylactic
treatment, retinal detachment, retinal tear.
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